Key result
In-hospital mortality and cumulative mortality were not different between heart failure patients with reduced versus non-reduced ejection fraction.
Why the study?
Does heart failure with reduced ejection fraction (LVEF < 40%) compared to non-reduced ejection fraction (LVEF ≥ 40%) affect mortality in hospitalized heart failure patients?
Cohort (n=1,182)
No
Does heart failure with reduced ejection fraction (LVEF < 40%) compared to non-reduced ejection fraction (LVEF ≥ 40%) affect mortality in hospitalized heart failure patients?
Answers are grounded in this paper and cite their sources.
Despite significant differences in clinical characteristics and comorbidities, patients hospitalized with HFrEF and non-HFrEF have similar in-hospital and cumulative mortality.
Objective To compare the clinical characteristics, and outcomes among patients with heart failure with reduced(HFrEF) versus non-reduced(non-HFrEF) left ventricular ejection fractions. Methods 1 182 Consecutive patients hospitalized with heart failure(HF) at our center from April 2011 to July 2015 were enrolled in the present study with a median follow-up of 23.7 months. We classified patients as having either reduced(HFrEF, LVEF<40%, n=313) or non-reduced(non-HFrEF, LVEF≥40%, n=869) ejection fraction. Results (1) Patients with HFrEF had poorer NYHA functional class, larger baseline left ventricular end diastolic diameter, showed higher admission N termial B-type natriuretic peptide precursor(NT-proBNP), uric acid, hemoglobin values and were more likely to be treated with diuretics, ACE inhibitors/Angiotensin receptor blocker, aldosterone antagonist at discharge(all P<0.05), while those with non-HFrEF were more likely to be older and female and to have a history of ischemic heart disease, hypertensive etiology, anemia, atrial fibrillation, diabetes mellitus and stroke(all P<0.05). (2)The length of stay was longer in HFrEF patients(P=0.001). There were no significant difference between in-hospital death(P=0.797) and cumulative mortality(P=0.259) in patients with HFrEF and non-HFrEF.(3) In the multivariate Cox regression model, the predictors of death among patients with HFrEF included age, sex, sodium, NT-proBNP, while the predictors of the risk of death among those with non-HFrEF included age, NYHA functional class, NT-proBNP, albumin. Conclusions There were large differences in clinical characteristics between patients with HFrEF and those with non-HFrEF, while the in-hospital mortality and cumulative mortality for patients with HFrEF were not significantly different from those for patients with non-HFrEF.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2018) conducted a cohort in Heart failure (n=1,182). Reduced ejection fraction (LVEF<40%) vs. Non-reduced ejection fraction (LVEF≥40%) was evaluated on In-hospital death and cumulative mortality (p=0.259 for cumulative mortality). In-hospital mortality and cumulative mortality were not different between heart failure patients with reduced versus non-reduced ejection fraction.
Synapse has enriched 10 related papers. Consider them for comparative context: